Q32 Bio to Participate in the 2026 Jefferies Global Healthcare Conference in London
WALTHAM, Mass., Nov. 11, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical-stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today announced that management will...